A fresh generation of fast-acting anti-depressants is in the offing, says John H. Krystal, M.D., of Yale University School of Medicine—and perhaps also much-needed medications for PTSD. In a webinar broadcast by BBRF, Dr. Krystal explained how basic research on the biology of PTSD and depression led to a trial he is currently leading focusing on veterans and active-duty military with PTSD.
Read More